stock
ORKA · Oruka Therapeutics, Inc.
What Oruka Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live ORKA price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ORKA.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 66,209,699 as of 2026-07-31 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -11.9%
- ROA
- -11.7%
Health
- Current ratio
- 38.5x
- Debt/equity
- —
Deep value
- NCAV
- $859.71M
- NCAV per share
- $12.98
- Price/NCAV
- Locked
- NNWC
- $243.63M
- NNWC per share
- $3.68
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | — | —Gross profit: unreported by this company. | -$50.11M | -$41.21M | 10-Q filed 2026-08-10 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | -$36.43M | -$31.82M | 10-Q filed 2026-08-10 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | — | —Gross profit: unreported by this company. | -$34.43M | -$29.58M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | — | —Gross profit: unreported by this company. | -$34.10M | -$30.28M | 10-Q filed 2025-11-12 |
| 2025-06-30 | — | —Gross profit: unreported by this company. | -$28.43M | -$24.57M | 10-Q filed 2026-08-10 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | -$25.09M | -$21.00M | 10-Q filed 2026-08-10 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | — | —Gross profit: unreported by this company. | — | -$30.85M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | — | —Gross profit: unreported by this company. | -$29.45M | -$28.62M | 10-Q filed 2025-11-12 |
- Assets
- $1.14B
- Equity
- $1.11B
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$122.05M | -$105.43M | -$88.42M |
| 2024-12-31 | — | — | -$83.72M | — |
| 2023-12-31 | $0 | -$7.30M | -$5.34M | -$5.01M |
| 2022-12-31 | $0 | -$10.60M | -$9.93M | -$10.91M |
| 2021-12-31 | $0 | -$19.34M | -$19.32M | -$18.80M |
| 2020-12-31 | $0 | -$9.77M | -$9.74M | -$7.74M |
| 2019-12-31 | $0 | -$5.81M | -$5.48M | -$4.80M |
| 2018-12-31 | $0 | -$8.12M | -$7.93M | -$8.25M |
| 2017-12-31 | $0 | -$18.71M | -$18.49M | -$17.48M |
| 2016-12-31 | $0 | -$16.61M | -$16.44M | — |
Company filings
since Fri Aug 21 · 7 offering filings in 12 months · since Fri Aug 28
events
Executive or director change
Executive or director changeAug 248-KResults
ResultsAug 108-KShareholder vote results
Shareholder vote resultsJun 48-KOther event
Other eventJun 18-KResults, Other event
ResultsOther eventApr 308-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventApr 278-K
5% owners ()
Venrock Healthcare Capital Partners III, L.P.
Stake update
VIKING GLOBAL INVESTORS LP
Stake update
RTW Investments, LP
Passive stake
Capital World Investors
Passive stake
Fairmount Funds Management LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Klein Lawrence Otto
Chief Executive Officer, Director
Sale$2,090,593Oct 2, 7:54 PM ET
Agarwal Arjun
Senior Vice President, Finance
Sale$51,035Sep 21, 5:38 PM ET
Quinlan Paul T
General Counsel
Sale$936,417Sep 21, 4:57 PM ET
Goncalves Joana
Chief Medical Officer
Sale$734,145Sep 15, 7:18 PM ET
Agarwal Arjun
Senior Vice President, Finance
Sale$926,010Sep 15, 7:17 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Viking Global
Period Tue 30 Jun 2026
0.4%Trimmed
News
Stories that named ORKA, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about ORKA.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on ORKA come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ORKA board